45 related articles for article (PubMed ID: 36822899)
21. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
Toh TB; Lim JJ; Hooi L; Rashid MBMA; Chow EK
J Hepatol; 2020 Jan; 72(1):104-118. PubMed ID: 31541681
[TBL] [Abstract][Full Text] [Related]
22. [Differential diagnostic between hepatocellular carcinoma and hepatoid carcinoma with bone metastasis revelation: What tools can be used?].
Neyrand S; Bringuier PP; Benzerdjeb N; Hervieu V; Fenouil T
Ann Pathol; 2023 Sep; 43(5):407-411. PubMed ID: 36822899
[TBL] [Abstract][Full Text] [Related]
23. Hepatoid adenocarcinoma of the lung: report of five cases and review of the literature.
Haninger DM; Kloecker GH; Bousamra Ii M; Nowacki MR; Slone SP
Mod Pathol; 2014 Apr; 27(4):535-42. PubMed ID: 24030743
[TBL] [Abstract][Full Text] [Related]
24. Hepatoid tumors of the gastrointestinal/pancreatobiliary district: morphology, immunohistochemistry, and molecular profiles.
Mattiolo P; Scarpa A; Luchini C
Hum Pathol; 2023 Feb; 132():169-175. PubMed ID: 35714834
[TBL] [Abstract][Full Text] [Related]
25. Hepatoid adenocarcinoma of the lung: Review of a rare form of lung cancer.
Grossman K; Beasley MB; Braman SS
Respir Med; 2016 Oct; 119():175-179. PubMed ID: 27692141
[TBL] [Abstract][Full Text] [Related]
26. Hepatoid carcinoma of the stomach.
deLorimier A; Park F; Aranha GV; Reyes C
Cancer; 1993 Jan; 71(2):293-6. PubMed ID: 7678544
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological characteristics in the differential diagnosis of hepatoid adenocarcinoma: a literature review.
Su JS; Chen YT; Wang RC; Wu CY; Lee SW; Lee TY
World J Gastroenterol; 2013 Jan; 19(3):321-7. PubMed ID: 23372352
[TBL] [Abstract][Full Text] [Related]
28. Hepatoid adenocarcinoma: a new clinicopathological entity and the hypotheses on carcinogenesis.
Kishimoto T; Nagai Y; Kato K; Ozaki D; Ishikura H
Med Electron Microsc; 2000; 33(2):57-63. PubMed ID: 11810459
[TBL] [Abstract][Full Text] [Related]
29. Carcinoma of the stomach with hepatocyte differentiation (hepatoid adenocarcinoma).
Roberts CC; Colby TV; Batts KP
Mayo Clin Proc; 1997 Dec; 72(12):1154-60. PubMed ID: 9413299
[TBL] [Abstract][Full Text] [Related]
30. Gastrointestinal hepatoid adenocarcinoma: venous permeation and mimicry of hepatocellular carcinoma, a report of four cases.
Ishikura H; Kishimoto T; Andachi H; Kakuta Y; Yoshiki T
Histopathology; 1997 Jul; 31(1):47-54. PubMed ID: 9253624
[TBL] [Abstract][Full Text] [Related]
31. [A case of liver metastasis from so-called hepatoid adenocarcinoma of stomach with lipiodol accumulation].
Ueda H; Yoshikawa K; Hashimoto T; Yamaguchi T; Dousei T; Moriguchi A; Taniguchi M; Taketani S; Kawano K; Tsujimura T
Nihon Shokakibyo Gakkai Zasshi; 1996 Feb; 93(2):120-5. PubMed ID: 8865753
[No Abstract] [Full Text] [Related]
32. Hepatoid adenocarcinoma of the stomach.
Inagawa S; Shimazaki J; Hori M; Yoshimi F; Adachi S; Kawamoto T; Fukao K; Itabashi M
Gastric Cancer; 2001; 4(1):43-52. PubMed ID: 11706627
[TBL] [Abstract][Full Text] [Related]
33. Pancreatic hepatoid carcinoma: a review of the literature.
Marchegiani G; Gareer H; Parisi A; Capelli P; Bassi C; Salvia R
Dig Surg; 2013; 30(4-6):425-33. PubMed ID: 24281319
[TBL] [Abstract][Full Text] [Related]
34. [Carcinoma hepatoides of the stomach --case report and literature review].
Górnicka B; Ziarkiewicz-Wróblewska B; Muszyński J; Wróblewski T; Bogdańska M; Morton M; Wasiutyński A
Wiad Lek; 2003; 56(9-10):481-5. PubMed ID: 15049215
[TBL] [Abstract][Full Text] [Related]
35. Gastric metastasis of recurrent hepatocellular carcinoma: A case report and literature review.
Peng L; Yu K; Li Y; Xiao W
J Cancer Res Ther; 2018 Dec; 14(Supplement):S1230-S1232. PubMed ID: 30539878
[TBL] [Abstract][Full Text] [Related]
36. Solitary extrahepatic hepatocellular carcinoma in vertebrae without a primary lesion in the liver might originate from bone marrow: a case report and new hypothesis based on a review of the literature and the latest findings.
Shirota Y; Ueda Y; Sato K; Takeda Y; Hodo Y; Wakabayashi T
Clin J Gastroenterol; 2022 Dec; 15(6):1115-1123. PubMed ID: 36109475
[TBL] [Abstract][Full Text] [Related]
37. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
[TBL] [Abstract][Full Text] [Related]
38. Exploring the JAK/STAT Signaling Pathway in Hepatocellular Carcinoma: Unraveling Signaling Complexity and Therapeutic Implications.
Park H; Lee S; Lee J; Moon H; Ro SW
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762066
[TBL] [Abstract][Full Text] [Related]
39. Primary hepatoid adenocarcinoma of the uterine cervix.
Kato K; Suzuka K; Osaki T; Itami M; Tanaka N
Int J Gynecol Cancer; 2007; 17(5):1150-4. PubMed ID: 17367323
[TBL] [Abstract][Full Text] [Related]
40. Hepatoid Adenocarcinoma of the Stomach: Current Perspectives and New Developments.
Xia R; Zhou Y; Wang Y; Yuan J; Ma X
Front Oncol; 2021; 11():633916. PubMed ID: 33912455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
